A study published in August 2025 found that lean muscle mass loss via a mouse model was less than previous studies had reported, and also found that a good portion of the And research presented at the European Congress on Obesity (ECO 2025) reported that adults taking GLP-1 drugs were able to retain muscle while losing weight by strength training and eating enough protein
Back Lasker Foundation (2024) 'GLP-1-based therapy for obesity'
Cloning and follicle banking have entered the chat
In consideration of the multiple metabolic and cardiovascular effects seen in subjects treated with GLP-1RAs and SGLT-2is (e.g., reduction of hyperglycemia, weight loss, free/fat mass and bone remodeling, anti-atherosclerosis, natriuresis), it is reasonable to speculate that GH and IGF-1 may play a about a relevant role in this context
BPC-157 is a synthetic 15-amino acid peptide derived from human gastric juice that demonstrates significant wound healing properties in preclinical research
Lab77 Peptides does not provide therapeutic claims, dosing guidance, administration protocols, or any content relating to human or veterinary use